Annual report pursuant to Section 13 and 15(d)

Accrued Expenses

v3.3.1.900
Accrued Expenses
12 Months Ended
Dec. 31, 2015
Payables And Accruals [Abstract]  
Accrued Expenses

8.

ACCRUED EXPENSES

Accrued expenses consisted of the following:

 

 

 

December 31,

 

 

 

2015

 

 

2014

 

Accrued clinical operations and trials costs

 

$

365,188

 

 

$

 

Accrued product development costs

 

 

152,018

 

 

 

114,757

 

Accrued audit fees

 

 

16,500

 

 

 

50,000

 

Accrued payroll

 

 

 

 

40,734

 

Accrued other

 

 

28,573

 

 

 

44,000

 

Total

 

$

562,279

 

 

$

249,491